II. Definitions
- Ectopic Pregnancy
 - Pregnancy of Unknown Location
- Positive Pregnancy Test but no intrauterine pregnancy or ectopic visible on Transvaginal Ultrasound
 - Accounts for up to half of ectopic pregnancies
 
 
III. Epidemiology
- 
                          Prevalence: 1 to 2% of all pregnancies
- Ectopic Prevalence increases to 4 to 5% for maternal age >40 years
 - Ectopic Prevalence increases to 6 to 16% for pregnancy presentations with bleeding or pain
 - Ectopic Prevalence increases to 30% for prior Tubal Ligation, and 50% for pregnancy despite IUD in place
 
 - Second most common cause of maternal mortality
- Accounts for 2.7% of maternal deaths in U.S. (as high as 10-15% of maternal deaths in past)
 - Case fatality rate: 3.8 deaths per 10,000 ectopics
 
 
IV. Risk Factors
- No Known risk factor in 50% of cases
 - Highest risk factors
- Prior tubal surgery (Odds Ratio 21.0)
 - Sterilization such as Tubal Ligation (Odds Ratio 9.3)
 - Prior Ectopic Pregnancy (Odds Ratio 8.3, represents 11% of cases)
- History of 1 Ectopic Pregnancy: 10% risk of subsequent Ectopic Pregnancy
 - History of 2 ectopic pregnancies: 25% risk of subsequent Ectopic Pregnancy
 
 - Intrauterine Device (IUD) (Odds Ratio 5.0, represents 14% of cases)
 - In-vitro fertilization (with transfer of multiple Embryos)
- Associated with Heterotopic Pregnancy (Simultaneous intrauterine and Ectopic Pregnancy)
 
 - Diethylstilbestrol Exposure (DES Exposure) in utero (Odds Ratio 5.6)
 
 - Moderate risk factors
- Pelvic Inflammatory Disease or other tubal infection (Odds Ratio 3.4)
 - Prior fallopian tube surgery
 - Infertility for 2 years or longer (Odds Ratio 2.7, represents 15% of cases)
 - Multiple sexual partners
 - Advanced maternal age >35-40 years old (Odds Ratio 2.9)
 - Tobacco Abuse (via impaired tubal motility, Odds Ratio 3.9 for 1 ppd, 3.1 for 0.5 ppd)
 
 - Other risk factors
- Endometriosis
 - Mini Pill use (Progestin Only Pill)
 - Vaginal Douching
 - Early age at first intercourse (age <18 years)
 
 
V. Symptoms
- Pregnancy Symptoms (e.g. Amenorrhea, Nausea, Fatigue, Urinary Frequency, Breast engorgement)
 - Onset of symptoms occurs on average ~7 weeks after Last Menstrual Period
 - 
                          Abdominal Pain (>97% of cases)
- May be non-specific, sharp or crampy, diffuse or localized
 - Typically starts with colicky unilateral Abdominal Pain or Pelvic Pain (as fallopian tube dilates)
 - Pain generalizes with peritoneal signs after fallopian tube rupture and Hemorrhage
 
 - 
                          Vaginal Bleeding (75% of cases)
- Results from sloughing of Decidual endometrium
 - Decidual cast may falsely appear as products of conception (ectopic misdiagnosed as Miscarriage)
 - Varies from spotting to heavy bleeding with clots
 - Vaginal Bleeding may occur regardless of ectopic rupture
 
 - Other symptoms
- Syncope or Presyncope
 - Nausea or Vomiting
 - Shoulder Pain
 - Rectal pressure
 - Pain on stooling
 - Diarrhea
 
 
VI. Signs
- Precaution: Exam can not exclude Ectopic Pregnancy
- No Vaginal Bleeding in 30% of ectopic pregnancies
 - Negative pelvic exam in 10% of ectopic pregnancies
 - Buckley (1999) Ann Emerg Med 34:589-94 [PubMed]
 
 - Ectopic likelihood if Pelvic Pain and Vaginal Bleeding
- No risk factors: 18 to 39%
 - Risk factors: 54%
 - Mol (1999) Hum Reprod 14:2855-62 [PubMed]
 
 - Classic (15-50% of patients)
- Pelvic Pain or Abdominal Pain (97%)
- Initially localized pain
 - Pain later generalizes
 
 - Abdominal tenderness (91%)
 - First Trimester Bleeding (79%)
 
 - Pelvic Pain or Abdominal Pain (97%)
 - Commonly associated findings
- Adnexal tenderness (54%)
 - Cervical Motion Tenderness
 - Amenorrhea
 - Shoulder Pain
- Associated with ruptured Ectopic Pregnancy with Hemorrhage that directly irritates the phrenic nerve
 
 - BR sign
- Patient faints post Bowel Movement
 
 - Early Pregnancy Symptoms
 - Cullen's Sign (Periumbilical Bruising)
 - Nausea or Vomiting
 - Diarrhea
 - Dizziness
 - Ectopic Pregnancy ruptures between 6 and 12 weeks
 
 - Other Signs
- Orthostasis or Hypotension
 - Sinus Tachycardia
 - Low grade fever
 - Chadwick Sign (Cervix and vaginal Cyanosis)
 - Hegar's Sign (softened uterine isthmus)
 - Hypoactive bowel sounds
 - Enlarged Uterus
 - Tender pelvic or Adnexal Mass
 - Cul-de-sac fullness
 - Decidual cast (Passage of Decidua in one piece)
 
 - Signs suggestive of ruptured Ectopic Pregnancy
- Severe abdominal tenderness with rebound, gaurding
 - Orthostatic Hypotension
 
 
VII. Differential Diagnosis
- See First Trimester Bleeding
 - See Abdominal Pain in Pregnancy
 - Most common alternative diagnoses
- Appendicitis
 - Threatened Abortion
 - Early Pregnancy Loss (Miscarriage)
 - Ruptured Ovarian Cyst (corpus luteum)
 - Pelvic Inflammatory Disease
- Salpingitis
 - Endometritis
 
 - Ureterolithiasis
 - Ovarian Torsion
 - Intrauterine Pregnancy
 - Subchorionic Hemorrhage
 - Abdominal Trauma
 
 - Other alternative diagnoses
- Heterotopic Pregnancy
- Rare in general population (1 case in 30,000 women)
 - Common for those undergoing in vitro fertilization (1 case in 100 women)
 
 - Dysmenorrhea
 - Dysfunctional Uterine Bleeding
 - Urinary Tract Infection
 - Diverticulitis
 - Mesenteric Lymphadenitis
 
 - Heterotopic Pregnancy
 
VIII. Labs
- See Imaging below
 - 
                          Quantitative hCG
                          
- HCG increases in a predictable pattern in normal pregnancies
- bHCG may be detectable as early as 8 days after Ovulation
 - bHCG <1500: Increases 49-53% (and typically doubles) every 48 hours in 99% of normal pregnancies
 - bHCG 1500 to 3000: Increases 40% every 48 hours in normal pregnancies
 - bHCG >3000: Increases 33% every 48 hours in normal pregnancies
 - Levels off after bHCG reaches 100,000 at approximately 8-10 weeks gestation
 - Barhart (2016) Obstet Gynecol 128(3): 504-11 [PubMed]
 
 - bHCG with inadequate increase may suggest Ectopic Pregnancy
- Test Sensitivity: 36% (some studies report 71%)
 - Test Specificity: 65%
 - bHCG also increases inadequately (<50%) in 1% of viable pregnancies
 - bHCG decreases by <35% in up to 7% of 10% of Spontaneous Abortions
 
 - bHCG should not be used to defer Ultrasound when Ectopic Pregnancy is considered
- Intrauterine pregnancy is first confirmed on Transvaginal Ultrasound at bHCG 1500-2000 IU/L
- In some cases intrauterine pregnancy may not be visible until bHCG >3500 IU/L
 
 - However, 40% of ectopic pregnancies are identified at bHCG less than 1000 mIU/ml
 - Ectopic pregnancies have occurred with bHCG as low as 10 mIU/ml
 
 - Intrauterine pregnancy is first confirmed on Transvaginal Ultrasound at bHCG 1500-2000 IU/L
 - bHCG level does not predict ruptured ectopic
- Ruptured ectopic may occur at any bHCG level
 
 - bHCG must be followed serially with all management protocols
- Follow bHCG to non-detectable levels (may need as long as 6 weeks)
 - If bHCG start to rise again after falling, repeat Ultrasound is needed
 
 
 - HCG increases in a predictable pattern in normal pregnancies
 - 
                          Blood Type and Rh, hold units
- Rh Negative women should be administered 300 mcg (or 50 mcg) RhoGAM if bleeding
 
 - Complete Blood Count
 - Urinalysis with microscopic exam
 - Culdocentesis
- Rarely performed now due to Transvaginal Ultrasound
 - Differentiates ruptured Ovarian Cyst from ectopic
 - Yield of aspirate with >15% Hematocrit suggests bleed
 
 - Tests not recommended for ectopic diagnosis
 
IX. Imaging
- Precautions
- Transvaginal Ultrasound should be performed regardless of bHCG level when Ectopic Pregnancy is considered
 - In 40% of Ultrasound diagnosed Ectopic Pregnancy cases, bHCG was below 1000 mIU/ml
 - Counselman (1998) J Emerg Med 16(5): 699-703 [PubMed]
 
 - 
                          General
- Findings suggestive of intrauterine pregnancy
- Intrauterine Gestational Sac suggests intrauterine pregnancy
 - Exceptions
- Pseudogestational sac (intrauterine fluid collection with no true Gestational Sack)
- No Echogenic ring
 - No Yolk Sac or fetal pole seen
 
 - Heterotopic Pregnancy (Simultaneous intrauterine and Ectopic Pregnancy)
- Overall Incidence: 1 in 4000 to 30,000 risk (rare)
 - Fertility patient Incidence: 1 in 300 (may be 1 in 30 for some types of assisted conception)
 - Ultrasound misses Heterotopic Pregnancy in 50% of cases at 5-6 weeks
 
 
 - Pseudogestational sac (intrauterine fluid collection with no true Gestational Sack)
 
 - Findings suggestive of Ectopic Pregnancy
- No mass or free fluid seen (20% likelihood)
 - Absence of Gestational Sac at bHCG 1500-1800 IU/L transvaginal or 6500 IU/L transabdominal (36% likelihood)
 - Echogenic mass at Adnexa (85% likelihood)
- Echogenic mass with free fluid (100% likelihood)
 - Transvaginal Ultrasound demonstrates 75% of tubal ectopic pregnancies
 
 - Free fluid present (71% likelihood of ectopic)
- Moderate to large free fluid in pouch of Douglas (95% likelihood)
 - False Positive (other causes of free fluid in pouch of douglas)
- Ruptured corpus luteum cyst
 - Spontaneous Abortion
 - Menses
 
 
 
 
 - Findings suggestive of intrauterine pregnancy
 - 
                          Transvaginal Ultrasound (5 MHz or greater)
- Test Sensitivity: 90%
 - Test Specificity approaches 100%
 - Gestational Sac of 5 mm (Days 35-37 or 4.5 to 5 weeks, bHCG 1500-2000)
- Earliest finding in pregnancy, but does not exclude Ectopic Pregnancy
 - Double Decidual sac sign (2 bright concentric ring around the Gestational Sac)
 - Case reports of absent Gestational Sac on Ultrasound in viable pregnancies with bHCG as high as 4300 mIU/ml
 
 - Yolk Sac (Days 37-40 or 5-6 weeks, gestation sac>10 mm)
- Confirms intrauterine pregnancy (100% Positive Predictive Value)
 
 - Fetal Pole (Day 40, Gestational Sac>18 mm, bHCG 5000)
 - Fetal Heart Activity (Day 45 or 6-7 weeks, crown rump length >5 mm, bHCG 17,000)
 
 - Transabdominal Ultrasound
- Gestational Sac (Day 42, bHCG 6000-6500)
 - Evaluate pouch of douglas for free fluid (see above)
 
 - 
                          FAST Exam
                          
- Free fluid in Morrison's pouch or in Pelvis on Abdominal Ultrasound may warrant emergent surgery
 
 
X. Evaluation
- Indications
- Positive Pregnancy Test AND
 - Pelvic Pain or Vaginal Bleeding
 
 - Step 1: History and physical
- Unstable
- Go to emergent protocol below
 
 - Stable
- Go to step 2
 
 
 - Unstable
 - Step 2: Transvaginal Ultrasound
 - Step 3a: Initial bHCG above discriminatory level (e.g. >1500 mIU on Transvaginal Ultrasound)
- Treat suspicious Adnexal Mass as Ectopic Pregnancy
 - Repeat bHCG and Transvaginal Ultrasound in 2 days if no Gestational Sac or Adnexal Mass identified
- Treat as Ectopic Pregnancy if bHCG fails to rise appropriately
 - Treat as normal pregnancy if Transvaginal Ultrasound confirms IUP
 - Follow weekly bHCG until 0 mIU/ml if decreases
 - Repeat bHCG and Transvaginal Ultrasound in 2 days if bHCG has normal rise (but nondiagnostic Ultrasound)
 
 
 - Step 3b:	Initial bHCG below discriminatory level (e.g. <1500 mIU on Transvaginal Ultrasound)
- At any point that patient has signficant symptoms or becomes unstable, treat as ectopic with emergent protocol below
 - Repeat bHCG every 48 hours
 - bHCG decreasing (intrauterine or ectopic failed pregnancy)
- Obtain weekly bHCG levels until falls to <5 mIU/ml
 
 - bHCG rises normally
- Repeat Transvaginal Ultrasound when discriminatory level reached (e.g. <1500 mIU)
 
 - bHCG plateaus or with inadequate rise
- Obtain Transvaginal Ultrasound
 - Manage medically or surgically as failed pregnancy (ectopic or intrauterine)
- If Transvaginal Ultrasound negative or with Adnexal Mass
 
 
 
 
XI. Approach: Ultrasound, bHCG with D&C
- Indications
- Pregnancy with cramping and Vaginal Bleeding AND
 - Patient stable AND
 - Pregnancy NOT desired
 
 - Step 1: Pelvic Ultrasound
- Intrauterine Pregnancy: Routine Prenatal Care
 - Ectopic Pregnancy
- See Ectopic Pregnancy Management below
 - See Methotrexate Ectopic Protocol
 
 - Abnormal Intrauterine Pregnancy: D&C (see Step 3)
 - Non-Diagnostic Ultrasound: Go to Step 2 below
 
 - Step 2: Quantitative hCG
- Transvaginal Ultrasound discriminatory bHCG <1500 to 2000 mIU/ml
 - bHCG <2000 mIU/ml
- Go to Step 4 (expectant management with serial bHCG and repeat Ultrasound)
 
 - bHCG 2000-3500 mIU/ml
- Go to Step 3
 - Negative Transvaginal Ultrasound is unlikely to be a viable pregnancy
 - Ideal, safe timing for medical management with Methotrexate (see below)
- However, outlawed in some U.S. states for bHCG <3500 mIU/ml as of 2025
 
 
 - bHCG >3500 mIU/ml
- Go to Step 3
 - Negative Transvaginal Ultrasound is consistent with Ectopic Pregnancy and high risk of rupture
 
 
 - Step 3: Dilatation and Curettage (D&C, if HCG > cutoff)
- D&C shows chorionic villi: Routine care for failed intrauterine pregnancy
 - D&C shows no chorionic villi: Treat as Ectopic Pregnancy
- Treat with Medical or Surgical Management for Ectopic Pregnancy
 
 
 - Step 4: Serial Quantitative hCG (if bHCG < cutoff)
- Normal fall: Manage as Miscarriage
 - Abnormal rise or fall in HCG: D&C (see Step 3)
 - Normal HCG rise
- Ultrasound when HCG > cutoff
 - Go to Step 1
 
 - Precaution
- Symptomatic Ectopic Pregnancy can occur prior to HCG of 2000 (before discriminatory values)
 
 
 
XII. Approach: Emergent
- Indications
- Suspected ruptured Ectopic Pregnancy
 - Hemoperitoneum (significant intraperitoneal fluid presumed to be Hemorrhage)
 - Hemorrhagic Shock
 - Abdominal Pain with peritoneal signs
 - Open cervical os
 
 - Evaluation protocol
- Consult Ob/Gyn early in suspected Ectopic Pregnancy with hemodynamic instability
- Surgical exploration and stabilization is indicated
 
 - Obtain IV Access with 2 large bore IVs
 - Obtain labs as above (including bHCG, Blood Type and Cross)
 - Fluid Resuscitation and Blood Transfusion for Hemorrhagic Shock
 - Bedside Transvaginal Ultrasound (if available)
 
 - Consult Ob/Gyn early in suspected Ectopic Pregnancy with hemodynamic instability
 
XIII. Management: Treatment protocols
- See Approach above
 - Precautions
- Follow bHCG to non-detectable levels regardless of management strategy (up to 6 weeks)
 - If bHCG starts to rise again after falling, repeat Ultrasound is needed
 - Expectant management carries the highest risk of complication and is less commonly followed
 - Medical management with Methotrexate is followed in 20-35% of cases, and the remaining majority are managed surgically
 
 - All patients
- RhoGAM for Rh Negative women with Vaginal Bleeding
 
 - Expectant Management indications (counsel regarding tube rupture risk; follow bHCG every 48 hours, then weekly)
- Minimal pain or bleeding
 - Reliable patient with no barriers to follow-up and accessing healthcare
 - bHCG less than 1000 mIU/ml and falling
 - No signs of tubal rupture
 - Ectopic or Adnexal Mass <3 cm or not detected
 - No Embryonic heart beat
 - Cohen (1999) Clin Obstet Gynecol 42:48-54 [PubMed]
 
 - Medical Management: Methotrexate Indications
- See Methotrexate Ectopic Protocol
 - Reliable patient with no barriers to follow-up and accessing healthcare
 - Stable Vital Signs with normal LFTs, CBC, Platelets
 - Unruptured Ectopic Pregnancy without cardiac activity
 - Ectopic mass 3.5 cm or less
 - bHCG <5000 mIU/ml
 - No medical contraindications
- Liver, Kidney, lung or hematologic condition
 - Immunodeficiency
 - Peptic Ulcer Disease
 - Alcohol Abuse
 - Breastfeeding
 
 
 - Surgical Management Indications (Salpingectomy or if desired fertility, and possible, Salpingostomy)
- Failed or contraindicated non-surgical management
 - Nondiagnostic Transvaginal Ultrasound and bHCG >1500
 - bHCG >5000 IU/L
 - Hemoperitoneum
 - Diagnosis unclear
 - Advanced Ectopic Pregnancy (high B-HCG, large mass, Embryonic cardiac activity)
 - Non-compliant patient
 - Unstable Vital Signs
 
 
XIV. Complications
- Intraabdominal ruptured viscus (e.g. fallopian tube) with secondary Hemorrhagic Shock
 - Ectopic Pregnancy accounts for 4 to 9% of pregnancy related deaths
 
XV. Prognosis: Future conception
- Conception rate post-ectopic: 77%
 - Recurrent Ectopic Pregnancy risk
- After first Ectopic Pregnancy: 5-20% risk (Odds Ratio 8.3)
 - After second Ectopic Pregnancy: 25-32% risk
 
 
XVI. References
- Cooper and Mehta (2025) Crit Dec Emerg Med 39(7): 27-33
 - Lall (2017) Crit Dec Emerg Med 31(1): 3-9
 - Kuppusamy (2013) Crit Dec Emerg Med 27(7): 2-7
 - Reed and Smalley (2022) Crit Dec Emerg Med 36(9): 12-3
 - Simpson in Gabbe (2002) Obstetrics, p. 743
 - Barash (2014) Am Fam Physician 90(1): 34-40 [PubMed]
 - Della-Giustina (2003) Emerg Med Clin North Am, p. 565 [PubMed]
 - Gracia (2001) Obstet Gynecol 97:464-70 [PubMed]
 - Hendriks (2019) Am Fam Physician 99(3): 166-74 [PubMed]
 - Hendriks (2020) Am Fam Physician 101(10): 599-606 [PubMed]
 - Lozeau (2005) Am Fam Physician 72:1707-20 [PubMed]
 - Mullany (2023) Womens Health 19:17455057231160349 +PMID: 36999281 [PubMed]
 - Tay (2000) West J Med 173:131-4 [PubMed]